Paper21396934
P-glycoprotein antagonists confer synergistic sensitivity to short-chain ceramide in human multidrug-resistant cancer cells.
Chapman JV and 4 others. Exp Cell Res, 2011. Cited by 15 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. P-glycoprotein antagonists confer synergistic sensitivity to short-chain ceramide in human multidrug-resistant cancer cells. Papers, record 21396934. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21396934
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- P-glycoprotein antagonists confer synergistic sensitivity to short-chain ceramide in human multidrug-resistant cancer cells.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| ATP Binding Cassette Transporter, Subfamily B, Member 1 | Major topic |
| Ceramides | Major topic |
| Drug Resistance, Multiple | Major topic |
| Drug Resistance, Neoplasm | Major topic |
| Ovarian Neoplasms | Major topic |
| Tamoxifen | Major topic |
| Antineoplastic Agents, Hormonal | |
| Antineoplastic Combined Chemotherapy Protocols | |
| Blotting, Western | |
| Drug Synergism | |
| Female | |
| Glucosyltransferases | |
| Humans | |
| Tumor Cells, Cultured |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 GM077391 | NIGMS NIH HHS | United States | R01GM077391 | PubMed and NIH |
| GM77391 | NIGMS NIH HHS | United States | R01GM077391 | PubMed and NIH |
Source NIH RePORTER
References72
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15845415 | Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense. | Toxicol Appl Pharmacol | 2005 | https://conductscience.org/library/papers/15845415 | PubMed |
| 2 | 11106681 | Synergistic cytotoxicity in solid tumor cell lines between N-(4-hydroxyphenyl)retinamide and modulators of ceramide metabolism. | J Natl Cancer Inst | 2000 | https://conductscience.org/library/papers/11106681 | PubMed |
| 3 | 18245173 | A role for ceramide in driving cancer cell resistance to doxorubicin. | FASEB J | 2008 | https://conductscience.org/library/papers/18245173 | PubMed |
| 4 | 14662772 | Role of multiple drug resistance protein 1 in neutral but not acidic glycosphingolipid biosynthesis. | J Biol Chem | 2004 | https://conductscience.org/library/papers/14662772 | PubMed |
| 5 | 11238696 | Targeting ceramide metabolism--a strategy for overcoming drug resistance. | J Natl Cancer Inst | 2001 | https://conductscience.org/library/papers/11238696 | PubMed |
| 6 | 15867385 | Glucosylceramide synthase blockade down-regulates P-glycoprotein and resensitizes multidrug-resistant breast cancer cells to anticancer drugs. | Cancer Res | 2005 | https://conductscience.org/library/papers/15867385 | PubMed |
| 7 | 11305904 | Enzymes of sphingolipid metabolism: from modular to integrative signaling. | Biochemistry | 2001 | https://conductscience.org/library/papers/11305904 | PubMed |
| 8 | 12558497 | Killing tumours by ceramide-induced apoptosis: a critique of available drugs. | Biochem J | 2003 | https://conductscience.org/library/papers/12558497 | PubMed |
| 9 | 9052757 | Tamoxifen activates cellular phospholipase C and D and elicits protein kinase C translocation. | Int J Cancer | 1997 | https://conductscience.org/library/papers/9052757 | PubMed |
| 10 | 12467215 | P-glycoprotein modulates ceramide-mediated sensitivity of human breast cancer cells to tubulin-binding anticancer drugs. | Mol Cancer Ther | 2002 | https://conductscience.org/library/papers/12467215 | PubMed |
| 11 | 2148864 | Glucosyceramide synthase of mouse kidney: further characterization with an improved assay method. | Arch Biochem Biophys | 1990 | https://conductscience.org/library/papers/2148864 | PubMed |
| 12 | 10692420 | Retroviral transfection of Madin-Darby canine kidney cells with human MDR1 results in a major increase in globotriaosylceramide and 10(5)- to 10(6)-fold increased cell sensitivity to verocytotoxin. Role of p-glycoprotein in glycolipid synthesis. | J Biol Chem | 2000 | https://conductscience.org/library/papers/10692420 | PubMed |
| 13 | 11391861 | Taxol-induced ceramide generation and apoptosis in human breast cancer cells. | Cancer Chemother Pharmacol | 2001 | https://conductscience.org/library/papers/11391861 | PubMed |
| 14 | 10702281 | Uncoupling ceramide glycosylation by transfection of glucosylceramide synthase antisense reverses adriamycin resistance. | J Biol Chem | 2000 | https://conductscience.org/library/papers/10702281 | PubMed |
| 15 | 1483461 | Metabolic effects of short-chain ceramide and glucosylceramide on sphingolipids and protein kinase C. | Eur J Biochem | 1992 | https://conductscience.org/library/papers/1483461 | PubMed |
| 16 | 15868961 | Quantitative and functional assay of MDR1/P170-mediated MDR in ascites cells of patients with ovarian cancer. | Anticancer Res | 2005 | https://conductscience.org/library/papers/15868961 | PubMed |
| 17 | 17828752 | ABCB1 G1199A polymorphism and ovarian cancer response to paclitaxel. | J Pharm Sci | 2008 | https://conductscience.org/library/papers/17828752 | PubMed |
| 18 | 15047220 | Expression of multidrug resistance-1 protein inversely correlates with paclitaxel response and survival in ovarian cancer patients: a study in serial samples. | Gynecol Oncol | 2004 | https://conductscience.org/library/papers/15047220 | PubMed |
| 19 | 15141021 | Overexpression of glucosylceramide synthase and P-glycoprotein in cancer cells selected for resistance to natural product chemotherapy. | Mol Cancer Ther | 2004 | https://conductscience.org/library/papers/15141021 | PubMed |
| 20 | 1360704 | Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. | Science | 1992 | https://conductscience.org/library/papers/1360704 | PubMed |
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39337312 | The Drug Transporter P-Glycoprotein and Its Impact on Ceramide Metabolism-An Unconventional Ally in Cancer Treatment. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39337312 | PubMed |
| 36980769 | Simultaneous Inhibition of Ceramide Hydrolysis and Glycosylation Synergizes to Corrupt Mitochondrial Respiration and Signal Caspase Driven Cell Death in Drug-Resistant Acute Myeloid Leukemia. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/36980769 | PubMed |
| 36058252 | Intrinsic adaptations in OXPHOS power output and reduced tumorigenicity characterize doxorubicin resistant ovarian cancer cells. | Biochim Biophys Acta Bioenerg | 2022 | https://conductscience.org/library/papers/36058252 | PubMed |
| 30962310 | Acid ceramidase promotes drug resistance in acute myeloid leukemia through NF-κB-dependent P-glycoprotein upregulation. | J Lipid Res | 2019 | https://conductscience.org/library/papers/30962310 | PubMed |
| 30060815 | Novel Sphingolipid-Based Cancer Therapeutics in the Personalized Medicine Era. | Adv Cancer Res | 2018 | https://conductscience.org/library/papers/30060815 | PubMed |
| 27703266 | LC-MS Based Sphingolipidomic Study on A2780 Human Ovarian Cancer Cell Line and its Taxol-resistant Strain. | Sci Rep | 2016 | https://conductscience.org/library/papers/27703266 | PubMed |
| 25964209 | Tamoxifen regulation of sphingolipid metabolism--Therapeutic implications. | Biochim Biophys Acta | 2015 | https://conductscience.org/library/papers/25964209 | PubMed |
| 25810474 | Challenges and Potential for Ovarian Preservation with SERMs. | Biol Reprod | 2015 | https://conductscience.org/library/papers/25810474 | PubMed |
| 25769964 | Modification of sphingolipid metabolism by tamoxifen and N-desmethyltamoxifen in acute myelogenous leukemia--Impact on enzyme activity and response to cytotoxics. | Biochim Biophys Acta | 2015 | https://conductscience.org/library/papers/25769964 | PubMed |
| 23510065 | Gaucher's disease and cancer: a sphingolipid perspective. | Crit Rev Oncog | 2013 | https://conductscience.org/library/papers/23510065 | PubMed |
Genes16
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/21396934
GET https://conductscience.org/api/papers/v1/21396934/references?page=2